AI-Assisted Diabetic Retinopathy Screening: A Real-World Deployment Case

End-of-lesson check

15 questions · take it digitally for instant feedback at tendril.neural-forge.io/learn/quiz/end-healthcare-AI-diabetic-retinopathy-screening-adults

1. A primary care network is planning to deploy AI for diabetic retinopathy screening. What is the most critical prerequisite before launching the screening program?

   1. Purchasing the most advanced AI imaging device available
   2. Establishing a clear referral pathway to ophthalmology for positive findings
   3. Requiring patients to fast before the screening appointment
   4. Hiring additional retinal specialists to review all AI outputs

2. Which statement best describes what FDA-cleared diabetic retinopathy AI can accomplish in a primary care setting?

   1. It can identify multiple different retinal diseases beyond diabetic retinopathy
   2. It can be operated by primary care staff at the point of care during a routine visit
   3. It can replace the need for any ophthalmology visit for diabetic patients
   4. It can determine the exact stage of retinopathy without specialist confirmation

3. A patient screens negative using AI for diabetic retinopathy but later develops vision problems. What does this scenario most likely illustrate about AI limitations?

   1. The AI has perfect sensitivity and the patient is malingering
   2. The primary care staff failed to operate the AI correctly
   3. The AI may produce false negatives and cannot replace periodic specialist evaluation
   4. The AI was improperly calibrated and should be recalled

4. What is the primary reason staff training on AI capabilities and limitations is essential before deploying diabetic retinopathy screening?

   1. To ensure staff can explain to patients why the AI is superior to ophthalmologists
   2. To prevent staff from over-relying on AI outputs or dismissing valid findings
   3. To satisfy FDA regulatory requirements for device operation
   4. To reduce the cost of the screening program

5. A primary care clinic integrates AI diabetic retinopathy screening into annual wellness visits for diabetic patients. Which workflow element is most important to ensure the screening achieves its intended purpose?

   1. Requiring patients to sign informed consent for AI analysis
   2. Scheduling patients for separate imaging appointments
   3. Assigning a specific staff member to operate the device and document results
   4. Ensuring the device is placed where it can be used during the patient's regular visit

6. Which outcome metric is most important to track after deploying AI diabetic retinopathy screening in a primary care network?

   1. The amount of time staff spend operating the AI
   2. The number of AI devices purchased and deployed
   3. The percentage of patients with positive AI findings who complete ophthalmology referral
   4. Patient satisfaction scores with the screening experience

7. When the AI flags a patient as having potential diabetic retinopathy, what is the appropriate next step in the care pathway?

   1. Repeat the AI screening in six months to confirm the finding
   2. Refer the patient to an ophthalmologist for definitive evaluation and treatment
   3. Inform the patient that no further action is needed since the AI detected the condition
   4. Schedule the patient for laser treatment at the primary care clinic

8. A diabetic retinopathy AI is trained to detect only one specific condition. What risk does this create if the AI is deployed without adequate patient education?

   1. Patients may skip their annual physical examination
   2. Patients may receive a negative result and believe they have no eye problems at all
   3. Patients may refuse the screening due to fear of lasers
   4. Patients may demand that the AI detect other retinal conditions

9. What is the primary purpose of including a quality assurance program with sample case review when deploying AI diabetic retinopathy screening?

   1. To verify that the AI is functioning correctly and staff are following protocols
   2. To satisfy insurance billing requirements for the screening
   3. To train the AI to improve its accuracy over time
   4. To generate data for marketing the AI solution to other clinics

10. A primary care clinic deploys AI diabetic retinopathy screening but does not establish a clear referral pathway. What is the most likely negative consequence?

    1. The AI will generate false positive results due to workflow disruption
    2. The AI will automatically refer patients to ophthalmology without staff input
    3. Patients with positive findings may not receive timely treatment, leading to worse outcomes
    4. The clinic will lose accreditation for practicing outside its scope

11. Which patient population benefits most from AI-assisted diabetic retinopathy screening in primary care?

    1. Patients with a family history of glaucoma
    2. Patients who already see an ophthalmologist regularly for eye care
    3. Patients with diabetes who do not have regular access to ophthalmology services
    4. Patients who are afraid of eye examinations

12. What does the lesson identify as a key difference between what AI can do and what is still required from healthcare providers in diabetic retinopathy screening?

    1. AI can bill insurance, but providers must collect patient co-payments
    2. AI can diagnose retinopathy, but providers must still perform the physical eye examination
    3. AI can operate autonomously, but providers must still be present in the room
    4. AI can identify findings, but providers must establish and manage referral pathways

13. A clinic wants to measure whether its AI diabetic retinopathy screening program is improving patient outcomes. Which metric directly measures this goal?

    1. Rate of vision loss among screened diabetic patients
    2. Number of patients screened per month
    3. Average time to operate the AI device
    4. Patient satisfaction with the screening experience

14. Why is patient education about diabetic retinopathy screening important even when using FDA-cleared AI?

    1. To reduce the time staff spend with each patient
    2. To help patients understand why screening is necessary and what results mean
    3. To explain to patients how the AI algorithm works technically
    4. To satisfy legal requirements for informed consent

15. What does the lesson indicate about deploying AI diabetic retinopathy screening in specialty ophthalmology practices?

    1. It should be avoided to prevent confusing patients about their care
    2. It is contraindicated because ophthalmologists would be offended
    3. The lesson does not specifically address this scenario
    4. It would not add value since patients already have access to specialists